- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The LFA-based Cardiac Marker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global LFA-based Cardiac Marker market size is estimated to be worth US$ 3699.5 million in 2021 and is forecast to a readjusted size of USD 6100.6 million by 2028 with a CAGR of 7.4% during review period. Laboratory Testing accounting for % of the LFA-based Cardiac Marker global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Troponin segment is altered to a % CAGR between 2022 and 2028.
Global key companies of LFA-based Cardiac Marker include Thermo Fisher, Bio-Rad Laboratories, Becton, Dickinson, Roche, and Hologic, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
LFA-based Cardiac Marker market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Troponin
CK-MB
Myoglobin
Others
Market segment by Application, can be divided into
Laboratory Testing
Point-of-care Testing
Market segment by players, this report covers
Thermo Fisher
Bio-Rad Laboratories
Becton, Dickinson
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioMérieux
LSI
Clinical Diagnostics
Randox laboratories
Wondfo Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe LFA-based Cardiac Marker product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of LFA-based Cardiac Marker, with revenue, gross margin and global market share of LFA-based Cardiac Marker from 2019 to 2022.
Chapter 3, the LFA-based Cardiac Marker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and LFA-based Cardiac Marker market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe LFA-based Cardiac Marker research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of LFA-based Cardiac Marker
1.2 Classification of LFA-based Cardiac Marker by Type
1.2.1 Overview: Global LFA-based Cardiac Marker Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global LFA-based Cardiac Marker Revenue Market Share by Type in 2021
1.2.3 Troponin
1.2.4 CK-MB
1.2.5 Myoglobin
1.2.6 Others
1.3 Global LFA-based Cardiac Marker Market by Application
1.3.1 Overview: Global LFA-based Cardiac Marker Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Global LFA-based Cardiac Marker Market Size & Forecast
1.5 Global LFA-based Cardiac Marker Market Size and Forecast by Region
1.5.1 Global LFA-based Cardiac Marker Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global LFA-based Cardiac Marker Market Size by Region, (2017-2022)
1.5.3 North America LFA-based Cardiac Marker Market Size and Prospect (2017-2028)
1.5.4 Europe LFA-based Cardiac Marker Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific LFA-based Cardiac Marker Market Size and Prospect (2017-2028)
1.5.6 South America LFA-based Cardiac Marker Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa LFA-based Cardiac Marker Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 LFA-based Cardiac Marker Market Drivers
1.6.2 LFA-based Cardiac Marker Market Restraints
1.6.3 LFA-based Cardiac Marker Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher LFA-based Cardiac Marker Product and Solutions
2.1.4 Thermo Fisher LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Bio-Rad Laboratories
2.2.1 Bio-Rad Laboratories Details
2.2.2 Bio-Rad Laboratories Major Business
2.2.3 Bio-Rad Laboratories LFA-based Cardiac Marker Product and Solutions
2.2.4 Bio-Rad Laboratories LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.3 Becton, Dickinson
2.3.1 Becton, Dickinson Details
2.3.2 Becton, Dickinson Major Business
2.3.3 Becton, Dickinson LFA-based Cardiac Marker Product and Solutions
2.3.4 Becton, Dickinson LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Becton, Dickinson Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche LFA-based Cardiac Marker Product and Solutions
2.4.4 Roche LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Roche Recent Developments and Future Plans
2.5 Hologic
2.5.1 Hologic Details
2.5.2 Hologic Major Business
2.5.3 Hologic LFA-based Cardiac Marker Product and Solutions
2.5.4 Hologic LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Hologic Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott LFA-based Cardiac Marker Product and Solutions
2.6.4 Abbott LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Siemens
2.7.1 Siemens Details
2.7.2 Siemens Major Business
2.7.3 Siemens LFA-based Cardiac Marker Product and Solutions
2.7.4 Siemens LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Siemens Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher LFA-based Cardiac Marker Product and Solutions
2.8.4 Danaher LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Alere
2.9.1 Alere Details
2.9.2 Alere Major Business
2.9.3 Alere LFA-based Cardiac Marker Product and Solutions
2.9.4 Alere LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Alere Recent Developments and Future Plans
2.10 BioMérieux
2.10.1 BioMérieux Details
2.10.2 BioMérieux Major Business
2.10.3 BioMérieux LFA-based Cardiac Marker Product and Solutions
2.10.4 BioMérieux LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 BioMérieux Recent Developments and Future Plans
2.11 LSI
2.11.1 LSI Details
2.11.2 LSI Major Business
2.11.3 LSI LFA-based Cardiac Marker Product and Solutions
2.11.4 LSI LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 LSI Recent Developments and Future Plans
2.12 Clinical Diagnostics
2.12.1 Clinical Diagnostics Details
2.12.2 Clinical Diagnostics Major Business
2.12.3 Clinical Diagnostics LFA-based Cardiac Marker Product and Solutions
2.12.4 Clinical Diagnostics LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Clinical Diagnostics Recent Developments and Future Plans
2.13 Randox laboratories
2.13.1 Randox laboratories Details
2.13.2 Randox laboratories Major Business
2.13.3 Randox laboratories LFA-based Cardiac Marker Product and Solutions
2.13.4 Randox laboratories LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Randox laboratories Recent Developments and Future Plans
2.14 Wondfo Biotech
2.14.1 Wondfo Biotech Details
2.14.2 Wondfo Biotech Major Business
2.14.3 Wondfo Biotech LFA-based Cardiac Marker Product and Solutions
2.14.4 Wondfo Biotech LFA-based Cardiac Marker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Wondfo Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global LFA-based Cardiac Marker Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 LFA-based Cardiac Marker Players Market Share in 2021
3.2.2 Top 10 LFA-based Cardiac Marker Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 LFA-based Cardiac Marker Players Head Office, Products and Services Provided
3.4 LFA-based Cardiac Marker Mergers & Acquisitions
3.5 LFA-based Cardiac Marker New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global LFA-based Cardiac Marker Revenue and Market Share by Type (2017-2022)
4.2 Global LFA-based Cardiac Marker Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global LFA-based Cardiac Marker Revenue Market Share by Application (2017-2022)
5.2 Global LFA-based Cardiac Marker Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America LFA-based Cardiac Marker Revenue by Type (2017-2028)
6.2 North America LFA-based Cardiac Marker Revenue by Application (2017-2028)
6.3 North America LFA-based Cardiac Marker Market Size by Country
6.3.1 North America LFA-based Cardiac Marker Revenue by Country (2017-2028)
6.3.2 United States LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
6.3.3 Canada LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
6.3.4 Mexico LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe LFA-based Cardiac Marker Revenue by Type (2017-2028)
7.2 Europe LFA-based Cardiac Marker Revenue by Application (2017-2028)
7.3 Europe LFA-based Cardiac Marker Market Size by Country
7.3.1 Europe LFA-based Cardiac Marker Revenue by Country (2017-2028)
7.3.2 Germany LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
7.3.3 France LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
7.3.4 United Kingdom LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
7.3.5 Russia LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
7.3.6 Italy LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific LFA-based Cardiac Marker Revenue by Type (2017-2028)
8.2 Asia-Pacific LFA-based Cardiac Marker Revenue by Application (2017-2028)
8.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Region
8.3.1 Asia-Pacific LFA-based Cardiac Marker Revenue by Region (2017-2028)
8.3.2 China LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
8.3.3 Japan LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
8.3.4 South Korea LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
8.3.5 India LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
8.3.7 Australia LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America LFA-based Cardiac Marker Revenue by Type (2017-2028)
9.2 South America LFA-based Cardiac Marker Revenue by Application (2017-2028)
9.3 South America LFA-based Cardiac Marker Market Size by Country
9.3.1 South America LFA-based Cardiac Marker Revenue by Country (2017-2028)
9.3.2 Brazil LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
9.3.3 Argentina LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa LFA-based Cardiac Marker Revenue by Type (2017-2028)
10.2 Middle East & Africa LFA-based Cardiac Marker Revenue by Application (2017-2028)
10.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Country
10.3.1 Middle East & Africa LFA-based Cardiac Marker Revenue by Country (2017-2028)
10.3.2 Turkey LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
10.3.4 UAE LFA-based Cardiac Marker Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global LFA-based Cardiac Marker Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global LFA-based Cardiac Marker Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market LFA-based Cardiac Marker Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global LFA-based Cardiac Marker Revenue (USD Million) by Region (2017-2022)
Table 5. Global LFA-based Cardiac Marker Revenue Market Share by Region (2023-2028)
Table 6. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Major Business
Table 8. Thermo Fisher LFA-based Cardiac Marker Product and Solutions
Table 9. Thermo Fisher LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories Major Business
Table 12. Bio-Rad Laboratories LFA-based Cardiac Marker Product and Solutions
Table 13. Bio-Rad Laboratories LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Becton, Dickinson Corporate Information, Head Office, and Major Competitors
Table 15. Becton, Dickinson Major Business
Table 16. Becton, Dickinson LFA-based Cardiac Marker Product and Solutions
Table 17. Becton, Dickinson LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche LFA-based Cardiac Marker Product and Solutions
Table 21. Roche LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Hologic Corporate Information, Head Office, and Major Competitors
Table 23. Hologic Major Business
Table 24. Hologic LFA-based Cardiac Marker Product and Solutions
Table 25. Hologic LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Abbott Corporate Information, Head Office, and Major Competitors
Table 27. Abbott Major Business
Table 28. Abbott LFA-based Cardiac Marker Product and Solutions
Table 29. Abbott LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Siemens Corporate Information, Head Office, and Major Competitors
Table 31. Siemens Major Business
Table 32. Siemens LFA-based Cardiac Marker Product and Solutions
Table 33. Siemens LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Danaher Corporate Information, Head Office, and Major Competitors
Table 35. Danaher Major Business
Table 36. Danaher LFA-based Cardiac Marker Product and Solutions
Table 37. Danaher LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Alere Corporate Information, Head Office, and Major Competitors
Table 39. Alere Major Business
Table 40. Alere LFA-based Cardiac Marker Product and Solutions
Table 41. Alere LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. BioMérieux Corporate Information, Head Office, and Major Competitors
Table 43. BioMérieux Major Business
Table 44. BioMérieux LFA-based Cardiac Marker Product and Solutions
Table 45. BioMérieux LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. LSI Corporate Information, Head Office, and Major Competitors
Table 47. LSI Major Business
Table 48. LSI LFA-based Cardiac Marker Product and Solutions
Table 49. LSI LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 51. Clinical Diagnostics Major Business
Table 52. Clinical Diagnostics LFA-based Cardiac Marker Product and Solutions
Table 53. Clinical Diagnostics LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Randox laboratories Corporate Information, Head Office, and Major Competitors
Table 55. Randox laboratories Major Business
Table 56. Randox laboratories LFA-based Cardiac Marker Product and Solutions
Table 57. Randox laboratories LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Wondfo Biotech Corporate Information, Head Office, and Major Competitors
Table 59. Wondfo Biotech Major Business
Table 60. Wondfo Biotech LFA-based Cardiac Marker Product and Solutions
Table 61. Wondfo Biotech LFA-based Cardiac Marker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global LFA-based Cardiac Marker Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global LFA-based Cardiac Marker Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of LFA-based Cardiac Marker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. LFA-based Cardiac Marker Players Head Office, Products and Services Provided
Table 66. LFA-based Cardiac Marker Mergers & Acquisitions in the Past Five Years
Table 67. LFA-based Cardiac Marker New Entrants and Expansion Plans
Table 68. Global LFA-based Cardiac Marker Revenue (USD Million) by Type (2017-2022)
Table 69. Global LFA-based Cardiac Marker Revenue Share by Type (2017-2022)
Table 70. Global LFA-based Cardiac Marker Revenue Forecast by Type (2023-2028)
Table 71. Global LFA-based Cardiac Marker Revenue by Application (2017-2022)
Table 72. Global LFA-based Cardiac Marker Revenue Forecast by Application (2023-2028)
Table 73. North America LFA-based Cardiac Marker Revenue by Type (2017-2022) & (USD Million)
Table 74. North America LFA-based Cardiac Marker Revenue by Type (2023-2028) & (USD Million)
Table 75. North America LFA-based Cardiac Marker Revenue by Application (2017-2022) & (USD Million)
Table 76. North America LFA-based Cardiac Marker Revenue by Application (2023-2028) & (USD Million)
Table 77. North America LFA-based Cardiac Marker Revenue by Country (2017-2022) & (USD Million)
Table 78. North America LFA-based Cardiac Marker Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe LFA-based Cardiac Marker Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe LFA-based Cardiac Marker Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe LFA-based Cardiac Marker Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe LFA-based Cardiac Marker Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe LFA-based Cardiac Marker Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe LFA-based Cardiac Marker Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific LFA-based Cardiac Marker Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific LFA-based Cardiac Marker Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific LFA-based Cardiac Marker Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific LFA-based Cardiac Marker Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific LFA-based Cardiac Marker Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific LFA-based Cardiac Marker Revenue by Region (2023-2028) & (USD Million)
Table 91. South America LFA-based Cardiac Marker Revenue by Type (2017-2022) & (USD Million)
Table 92. South America LFA-based Cardiac Marker Revenue by Type (2023-2028) & (USD Million)
Table 93. South America LFA-based Cardiac Marker Revenue by Application (2017-2022) & (USD Million)
Table 94. South America LFA-based Cardiac Marker Revenue by Application (2023-2028) & (USD Million)
Table 95. South America LFA-based Cardiac Marker Revenue by Country (2017-2022) & (USD Million)
Table 96. South America LFA-based Cardiac Marker Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa LFA-based Cardiac Marker Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa LFA-based Cardiac Marker Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa LFA-based Cardiac Marker Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa LFA-based Cardiac Marker Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa LFA-based Cardiac Marker Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa LFA-based Cardiac Marker Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. LFA-based Cardiac Marker Picture
Figure 2. Global LFA-based Cardiac Marker Revenue Market Share by Type in 2021
Figure 3. Troponin
Figure 4. CK-MB
Figure 5. Myoglobin
Figure 6. Others
Figure 7. LFA-based Cardiac Marker Revenue Market Share by Application in 2021
Figure 8. Laboratory Testing Picture
Figure 9. Point-of-care Testing Picture
Figure 10. Global LFA-based Cardiac Marker Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global LFA-based Cardiac Marker Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global LFA-based Cardiac Marker Revenue Market Share by Region (2017-2028)
Figure 13. Global LFA-based Cardiac Marker Revenue Market Share by Region in 2021
Figure 14. North America LFA-based Cardiac Marker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe LFA-based Cardiac Marker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific LFA-based Cardiac Marker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America LFA-based Cardiac Marker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa LFA-based Cardiac Marker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. LFA-based Cardiac Marker Market Drivers
Figure 20. LFA-based Cardiac Marker Market Restraints
Figure 21. LFA-based Cardiac Marker Market Trends
Figure 22. Thermo Fisher Recent Developments and Future Plans
Figure 23. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 24. Becton, Dickinson Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. Hologic Recent Developments and Future Plans
Figure 27. Abbott Recent Developments and Future Plans
Figure 28. Siemens Recent Developments and Future Plans
Figure 29. Danaher Recent Developments and Future Plans
Figure 30. Alere Recent Developments and Future Plans
Figure 31. BioMérieux Recent Developments and Future Plans
Figure 32. LSI Recent Developments and Future Plans
Figure 33. Clinical Diagnostics Recent Developments and Future Plans
Figure 34. Randox laboratories Recent Developments and Future Plans
Figure 35. Wondfo Biotech Recent Developments and Future Plans
Figure 36. Global LFA-based Cardiac Marker Revenue Share by Players in 2021
Figure 37. LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players LFA-based Cardiac Marker Revenue Market Share in 2021
Figure 39. Global Top 10 Players LFA-based Cardiac Marker Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global LFA-based Cardiac Marker Revenue Share by Type in 2021
Figure 42. Global LFA-based Cardiac Marker Market Share Forecast by Type (2023-2028)
Figure 43. Global LFA-based Cardiac Marker Revenue Share by Application in 2021
Figure 44. Global LFA-based Cardiac Marker Market Share Forecast by Application (2023-2028)
Figure 45. North America LFA-based Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 46. North America LFA-based Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 47. North America LFA-based Cardiac Marker Revenue Market Share by Country (2017-2028)
Figure 48. United States LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe LFA-based Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 52. Europe LFA-based Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 53. Europe LFA-based Cardiac Marker Revenue Market Share by Country (2017-2028)
Figure 54. Germany LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific LFA-based Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific LFA-based Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific LFA-based Cardiac Marker Revenue Market Share by Region (2017-2028)
Figure 62. China LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America LFA-based Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 69. South America LFA-based Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 70. South America LFA-based Cardiac Marker Revenue Market Share by Country (2017-2028)
Figure 71. Brazil LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa LFA-based Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa LFA-based Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa LFA-based Cardiac Marker Revenue Market Share by Country (2017-2028)
Figure 76. Turkey LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE LFA-based Cardiac Marker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
